Xaira Therapeutics Appoints Marc Tessier-Lavigne, Ph.D., as Chief Executive Officer
Position
Chief Executive Officer
Company
Xaira Therapeutics
BrisbaneBiotechnologyArtificial IntelligenceTherapeuticsMachine LearningDescription
Former Stanford president, Marc Tessier-Lavigne, Ph.D., has been appointed as the new Chief Executive Officer of Xaira Therapeutics, a leading biotech company with a significant focus on AI in drug discovery.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Shape Therapeutics Appoints Matt Valentino as Chief People Officer (May 2, 2024)
- Recursion Pharmaceuticals Appoints Najat Khan as Chief Commercial Officer and Head of R&D (April 19, 2024)
- Odysightai Appoints Einav Brenner as Chief Financial Officer (May 6, 2024)
- LQDX Appoints Simon McElrea as CEO and Rozalia Beica as Chief Commercial Officer (April 15, 2024)
- Anumana Appoints Harry S. Palmin as CFO and Ventures CFO (May 14, 2024)
- ThoughtSphere Appoints Dr. Avi Kulkarni as Chief Executive Officer (May 15, 2024)
Who to call at Xaira Therapeutics, and when
A new leader at Xaira Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Xaira Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Xaira Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Xaira Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Xaira Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Xaira Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.